Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents

E. V. Shubnikova; T. M. Bukatina; N. Yu. Velts; D. A. Kaperko; G. V. Kutekhova

Safety and Risk of Pharmacotherapy
Bezopasnostʹ i risk farmakoterapii

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

User

eng | рус

Safety and Risk of Pharmacotherapy

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Shubnikova E.V., Bukatina T.M., Velts N.Yu., Kaperko D.A., Kutekhova G.V. Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents. Safety and Risk of Pharmacotherapy. 2020;8(1):9-22. (In Russ.) https://doi.org/10.30895/2312-7821-2020-8-1-9-22

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Safety and Risk of Pharmacotherapy

For citations:

Cookies policy